Indications and uses
to sanitize hands without requiring water or a rinse kills 99.9% of most common germs
to sanitize hands without requiring water or a rinse kills 99.9% of most common germs
wet hands thoroughly with wipe allow to dry without rinsing
Benzalkonium chloride 0.13% w/w
Antimicrobial
In case of accidental ingestion, seek medical attention or contact a poison control center immediately.
to sanitize hands without requiring water or a rinse
kills 99.9% of most common germs
When using this product
do not use in or near eyes
discontinue use if irritation and redness develop
wet hands thoroughly with wipe allow to dry without rinsing
store at room temperature
Water, 2-Phenoxyethanol, Alkylpolyglucoside, C 8-10,C10-16, Lauramine,N,N-dimethyl, N-oxide, Tocopherol acetate, Aloe barbadensis leaf juice, PEG-40 Lanolin, Tetrasodium EDTA, Methylchloroisothiazolinone, Methylisothiazolinone.
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1038558 | benzalkonium chloride 0.13 % Medicated Pad | PSN | 1 |
| 1038558 | benzalkonium chloride 1.3 MG/ML Medicated Pad | SCD | 1 |
| 1038558 | benzalkonium chloride 0.13 % Topical Cloth | SY | 1 |
| 1038558 | benzalkonium chloride 0.13 % Topical Swab | SY | 1 |
| 1038558 | benzalkonium chloride 0.13 GM per 100 GM Topical Pad | SY | 1 |
| 1038558 | benzalkonium chloride 0.13 GM per 100 GM Topical Swab | SY | 1 |
| 1038558 | benzalkonium chloride 1 ML per 750 ML Topical Swab | SY | 1 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 59896-682-97 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-479d-60a7-e053-dbdaa90a05bd | 76bc4b39-1ac8-46e8-bd53-26c5c1c8704c |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59896-682-97 | MAYFAIR HAND SANITIZING WIPES WITH ALOE | 80 in 1 CANISTER | CLOTH | 80 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| BENZALKONIUM CHLORIDE | ACTIVE INGREDIENT | F5UM2KM3W7 | 1 | |
| BENZALKONIUM | ACTIVE MOIETY | 7N6JUD5X6Y | 1 | |
| .ALPHA.-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| COCAMINE OXIDE | INACTIVE INGREDIENT | QWA2IZI6FI | 1 | |
| DECYL GLUCOSIDE | INACTIVE INGREDIENT | Z17H97EA6Y | 1 | |
| EDETATE SODIUM | INACTIVE INGREDIENT | MP1J8420LU | 1 | |
| LAURAMINE OXIDE | INACTIVE INGREDIENT | 4F6FC4MI8W | 1 | |
| METHYLCHLOROISOTHIAZOLINONE | INACTIVE INGREDIENT | DEL7T5QRPN | 1 | |
| METHYLISOTHIAZOLINONE | INACTIVE INGREDIENT | 229D0E1QFA | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59896-682 | 59896-682-97 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | ACTIB |
| WATER | 059QF0KO0R | IACT |
| COCAMINE OXIDE | QWA2IZI6FI | IACT |
| DECYL GLUCOSIDE | Z17H97EA6Y | IACT |
| METHYLCHLOROISOTHIAZOLINONE | DEL7T5QRPN | IACT |
| METHYLISOTHIAZOLINONE | 229D0E1QFA | IACT |
| ALOE VERA LEAF | ZY81Z83H0X | IACT |
| LAURAMINE OXIDE | 4F6FC4MI8W | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | IACT |
| EDETATE SODIUM | MP1J8420LU | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | SHAMPOO / TOPICAL | 1.33 %w/w | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | INJECTION / INTRAMUSCULAR | 0.01 %w/v | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | EMULSION / OPHTHALMIC | 0.02 %w/v | ||
| LAURAMINE OXIDE | LAURAMINE OXIDE | 4F6FC4MI8W | SPONGE / TOPICAL | NA | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | SOLUTION / OPHTHALMIC | 0.1 %w/v | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | LOTION / TOPICAL | 0.17 %w/w | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| LAURAMINE OXIDE | LAURAMINE OXIDE | 4F6FC4MI8W | SOLUTION / TOPICAL | 3.5 %w/v | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | CAPSULE / ORAL | 1 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | INJECTION / INTRAVENOUS | 0.01 %w/v | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | SOLUTION / TOPICAL | 0.3 %w/w | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | SOAP / TOPICAL | 0.12 %w/w | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | INJECTION, SOLUTION / INTRAVENOUS | 0.04 %w/v | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | TABLET / ORAL | 5 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | SPONGE / TOPICAL | 0.14 %w/w | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2319b06e-741d-49fb-8a5a-c3afb6ac0b75 | 76bc4b39-1ac8-46e8-bd53-26c5c1c8704c | 2013-10-16 | Warnings | 2319b06e-741d-49fb-8a5a-c3afb6ac0b75 76bc4b39-1ac8-46e8-bd53-26c5c1c8704c |
Adverse event summaries are temporarily unavailable. Other product information remains available.